Table. 1.

Demographic characteristics of each study group

Variable Statistic Group A Group B Group C Group D1 Group D2 All subjects
No. of subjects - 4 4 4 4 4 20
Dose (CFU)a - 1 × 1011 3 × 1011 6 × 1011 9 × 1011 9 × 1011 -
Dietary controlb (N/Y) - N N N N Y -
Sex - Male Male Male Male Male -
Age (y) Mean (SD) 34.00 (13.14) 27.50 (9.47) 25.00 (1.63) 25.00 (3.56) 26.50 (2.65) 27.60 (7.53)
Height (cm) Mean (SD) 170.13 (8.63) 177.18 (7.99) 174.13 (5.45) 173.58 (8.95) 173.95 (3.86) 173.79 (6.84)
Weight (kg) Mean (SD) 70.13 (6.77) 79.30 (12.67) 72.18 (2.36) 72.25 (9.89) 78.75 (3.37) 74.52 (8.10)
BMI (kg/m2) Mean (SD) 24.20 (2.06) 25.15 (2.89) 23.75 (0.90) 23.88 (2.22) 25.98 (1.04) 24.59 (1.95)
Alcohol (g/wk)
Yes n (%) 4 (100.0) 0 (0.0) 3 (75.0) 4 (100.0) 1 (25.0) 12 (60.0)
No n (%) 0 (0.0) 4 (100.0) 1 (25.0) 0 (0.0) 3 (75.0) 8 (40.0)
Caffeine (cups/day)
Yes n (%) 3 (75.0) 3 (75.0) 3 (75.0) 2 (50.0) 1 (25.0) 12 (60.0)
No n (%) 1 (25.0) 1 (25.0) 1 (25.0) 2 (50.0) 3 (75.0) 8 (40.0)

Group A, administration of 1 capsule; Group B, administration of 3 capsules; Group C, administration of 6 capsules; Group D1, administration of 9 capsules without dietary control; Group D2, administration of 9 capsules with dietary control; BMI, body mass index; SD, standard deviation. aCFU, colony forming unit. 1 capsule is 1 × 1011 CFU. bGroup D2 was dietary controlled a week before GEN-001 administration.

Korean J Physiol Pharmacol 2024;28:153-164 https://doi.org/10.4196/kjpp.2024.28.2.153
© Korean J Physiol Pharmacol